Differential brain mechanisms in bipolar and unipolar disorders: Considerations from brain imaging

Brain Imaging in Affective Disorders

Volumn , Issue , 2002, Pages 337-362

  Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057253514     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (95)

1. u1957]
2. Goodwin FK, Jamison KR. Manic Depressive Illness. New York: Oxford University Press, 1990.
3. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152:1130-1138.
4. Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18: 435-440.
5. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania of hypomania. Am J Psychiatry 1992; 149:1633-1644.
6. Strakowski SM, Adler C, DelBello MP. Comparison of morphometric magnetic resonance imaging findings in bipolar disorder and unipolar depression. Bipolar Disord. In press.
7. Strakowski SM, DelBello MP, Adler C, Cecil KM, Sax KW. Neuroimage in bipolar disorder. Bipolar Disord 2000; 2:148-164.
8. Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck PE Jr, Hawkins JM. Frontosubcortical neuroanatomy and the Continuous Performance Test in mania. Am J Psychiatry 1999; 156:139-141.
9. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827.
10. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG. Fischer LA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz FA, McCarley RW. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156: 1091-1093.
11. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151:687-693.
12. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, Larson ER. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999; 56:254-260.
13. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear PK, Adler CM. Ventricular and periventricular structural volumes in first-vs. multiple-episode bipolar disorder. Am J Psychiatry. In press.
14. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 2001; 106:25-34.
15. Altshuler LL, Bartzokis G. Grieder T, Curran J, Jimenez T, Leight K, Wilkins J, Gemer R, Mintz J. An MRI study of temporal lobe structures in men with bipolar disorder and schizophrenia. Biol Psychiatry 2000; 48:147-162.
16. Swayze VW II, Andreasen NC, Alliger RJ. Yuh WTC, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31:221-240.
17. Pearlson GD, Barta PE, Powers RE, Menon RR, Richards SS, Aylward EH, Federman EB, Chase GA, Petty RG, Tien AY. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 1997; 41:1-4.
18. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121:561-579.
19. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology 1999; 21:63-68.
20. Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. Structural brain abnormalities in first-episode mania. Biol Psychiatry 1993; 33: 602-609.
21. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 1995; 152:1139-1144.
22. Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, Figiel GS, Spritzer CE. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993; 50:716.
23. Kumar A, Miller D, Ewbank D, Yousem D, Newberg A. Samuels S, Cowell P, Gottlieb G. Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am J Geriatr Psychiatry 1997; 5:15-25.
24. Pantel J, Schroder J, Essig M, Popp D, Dech H, Knopp MV, Schad LR, Eysen-back K, Backenstrass M, Gridelinger M. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord 1997; 42:69-83.
25. Kumar A, Jin Z, Bilker W, Udupa J, Gottlieb G. Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI. Proc Natl Acad Sci USA 1998; 95:7654-7658.
26. Lai T, Payne ME, Byrun CE, Steffens DC, Krishnan KR. Reduction of orbital frontal cortex volumes in geriatric depression. Biol Psychiatry 2000; 48:971-975.
27. Pillay SS, Renshaw PF, Bonello CM. Lafer BC, Fava M, Yurgelun-Todd D. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Psychiatry Res 1998; 84:61-74.
28. Krishnan KRR, McDonald WM, Doraiswamy PM, Tupler LA, Hussain M, Boyko OB, Figiel GS, Ellinwood EH. Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Neurosci 1993; 243:41-46.
29. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly: II. Postmortem pathological correlations. Stroke 1986, 17:1090-1097.
30. Chimowitz MI, Estes ML, Furlan AJ, Awad LA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49:247-752.
31. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. In: Uylings HBM, Van Eden CG, De Bruin JPC, Feenstra MGP, Pennartz CMA, eds. Progress in Brain Research, Vol 120. Elsevier Science, 2000:413-431.
32. Figiel GS, Krishnan KR, Doraiswamy PM, Rao VP, Nemeroff CB, Boyko OB. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neu-robiol Aging 1991; 12:245-247.
33. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller H, Chamey DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115-17.
34. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br J Psychiatry 1998; 172:527-532.
35. Sheline YI, Wang PW, Gado MH, Csemansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-3913.
36. McEwan BS, Angulo J, Cameron H. Chao HM, Daniels D, Gannon MN, Gould E, Mendelson S, Sakai R, Spencer R, Woolley C. Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol Psychiatry 1992; 31: 177-199.
37. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10: 2897-2902.
38. Ôngür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95:13290-13295.
39. Rajkowska G, Miguel-Hidalgo JJ, Wei J. Dilley G. Pittman SD. Meltzer HY, Oveerholseer JC, Roth BL, Stockmeier CA. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45:1085-1098.
40. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2000; 49:741-752.
41. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic dépressives. Biol Psychiatry 1998; 44:88-97.
42. Strakowski SM, Sax KW. Secondary mania: a model of the pathophysiology of bipolar disorder? In: Soares JC, Gershon S, eds. Basic Mechanisms and Therapeutic Implications of Bipolar Disorder. New York: Marcel Dekker, 2000: 13-30.
43. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR. Margolin R, Kessler RM. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984; 41:1159-1166.
44. Baxter LR. Phelps ME, Mazziotta JC, Schwartz JM, Gemer RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 1985; 42:441-447.
45. l8F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10:137-152.
46. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE. Ger-ner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250.
47. Ito H, Kawashima R, Awata S, Ono S, Sato K. Goto R, Koyama M, Sato M, Fukada H. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 1996; 37:410-414.
48. Blumberg HP, Stem E, Martinez D, Ricketts S, de Asis J, White T, Epstein J, McBride PA, Eidelberg D, Kocsis JH, Silbersweig DA. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 2000; 48:1045-1052.
49. Guze BH, Baxter LR Jr, Schwartz JM, Szuba MP, Mazziotta JC, Phelps ME. Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report. Psychiatry Res 1991; 40:195-202.
50. l2I]IMP in the differential diagnosis of psychiatric disorders. J Neuropsychiatry Clin Neurosci 1989; 1:145-153.
51. Rubin E, Sackeim HA, Prohovnik I, Moeller JR, Schnur DB, Mukherjee S. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiatry Res 1995; 61:1-10.
52. l8F-labeled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 1996; 169: 509-516.
53. Blumberg HP, Stem E, Ricketts S, Martinez D, de Asis J, White T, Epstein J, Isenberg N, McBride PA, Kemperman I, Emmerich S, Dhawan V, Eidelberg D, Kocsis JH, Silbersweig DA. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999; 156:1986-1988.
54. O’Connell RA, Van Heertum RL, Luck D. Yudd AP. Cueva JE, Billick SB, Cordon DJ, Gersh RJ, Masdeu JC. Single photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimage 1995; 5: 101-104.
55. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, Willis MW, Danielson A, Frye MA, Herscovitch P, Post RM. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001.
56. Yurgelun-Todd D. Gruber, SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar disorder. Bipolar Disord 2000; 2:237-248.
57. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000; 1120.
58. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156:675-682.
59. Drevets WC. Videen TO, Price JL, Preskom SH, Carmichael ST. Raichlc ME. A functional anatomical study of unipolar depression. J Neurosci 1992; 12: 3628-3641.
60. Biver F, Goldman S, Delvenne V, Luxen A, De Maertelaer V, Hubain P, Men-dlewicz J, Lotstra F. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994; 36:381-388.
61. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000; 48:830-843.
62. Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001; 158:899-905.
63. Brody AL, Sacena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, HO MK, Au SC, Maidment K, Baxter LR Jr. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58:631-640.
64. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or ven-lafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58: 641-648.
65. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE Jr. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999; 156:1149-1158.
66. Sharma R, Venkatasubramanian PN, Barany M, Davis JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 1992; 8:43-49.
67. Lafer B, Renshaw PF, Sachs G, Christensen JD, Yurgelun-Todd D, Stoll AL, Rosenbaum JF, Cohen BM. Proton MRS of the basal ganglia in bipolar patients (abstr). Biol Psychiatry 1994; 35:68S.
68. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y. Takahashi S, Inu-bushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996; 21:248-254.
69. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative proton magnetic spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998; 248:53-58.
70. Moore GJ, Bebchuk JM, Parrish JC, Faulk MW, Arfken CL, Strahl-Bevacqua J, Manji HK. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999; 156:1902-1908.
71. Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick B de B, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000; 2:207-216.
72. 3IP-MRS. J Affect Disord 1991; 22:185-190.
73. Kato T, Takahashi S, Shioiri T, Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorous-31 magnetic resonance spectroscopy. J Affect Disorder 1992; 26:223-230.
74. 7Li magnetic resonance spectroscopy. J Affect Disord 1993; 27:53-60.
75. Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-3 1 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res 1994; 55:41-50.
76. Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phospho-rous-31 magnetic resonance spectroscopy. J Affect Disord 1994; 31:125-133.
77. Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995; 152:915-918.
78. 31P-MRS. Psychol Med 1995; 25:557-566.
79. Deicken RF, Weiner MW, Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 1995; 33:195-199.
80. Charles HC, Lazeyras F, Krishnan RR, Boyko OB, Payne M, Moore D. Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neu-ropsychopharmacol Biol Psychiatry 1994; 18:1121-1127.
81. Renshaw PF, Lafer B, Babb S, Fava M, Stoll A, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1997; 41:837-843.
82. Frey R, Metzler D, Fischer P, Heiden A, Scharfetter J, Moser E, Kasper S. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. J Psychiatr Res 1998; 32:411-420.
83. Steingard RJ, Yurgelun-Todd DA, Hennen J, Moore JC, Moore CM, Vakili K, Young AD, Katie A, Beardslee WR, Renshaw PF. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 2000; 48:1053-1061.
84. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000; 47:305-313.
85. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur Arch Psychiatry Clin Neurosci 1998; 248:289-293.
86. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OAC, Berman RM, Chamey DS, Krystal JH. Reduced cortical -y-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56:1043-1047.
87. Miller BL, Chang L, Booth R, Ernst T, Comford M. Nikas D, et al. In vivo H-l MRS choline-correlation with in vitro chemistry histology. Life Sei 1996; 58:1929-1935.
88. Domino EF. Proton MRS of choline in brain and red blood cells: effects of lithium therapy. In: Nasrallah HA, Pettegrew JW, eds. NMR Spectroscopy in Psychiatric Brain Disorders. Washington DC: American Psychiatric Press, 1995:199-212.
89. Hallcher LM, Sherman WR. The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255:10896-10901.
90. Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD. Renshaw PF. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 1996; 40:382-388.
91. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter H, Savage CR, Fischman AJ. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51:62-70.
92. Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in Macaque monkeys. J Comp Neurol 1995; 363:615-641.
93. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880.
94. Soares JC, Mann JJ. The anatomy of mood disorders-review of structural neuroimage studies. Biol Psychiatry 1997; 41:86-106.
95. Starkstein SE, Federoff P, Berthier ML. Robinson RG. Manic-depressive and pure manic states after brain lesions. Biol Psychiatry 1991; 29:149-158.